Table 3.

Change scores for secondary outcomes from baseline (2007) to the end of the analysis period (2012)

CHARACTERISTICCONTROL GROUPINTERVENTION GROUPP VALUE
NMEAN CHANGE*95% CINMEAN CHANGE*95% CI
Body mass index, kg/m23090.15−0.13 to 0.4353−0.06−0.65 to 0.53.55
Systolic blood pressure, mm Hg364−0.41−1.41 to 0.5867−4.51−7.13 to −1.89.002
Diastolic blood pressure, mm Hg364−1.45−2.01 to −0.8167−3.12−4.69 to −1.56.04
HbA1c level, %920.11−0.07 to 0.2825−0.06−0.40 to 0.27.36
  • HbA1c—glycated hemoglobin A1c.

  • * Positive mean change values indicate an increase; negative mean change values indicate reduction.

  • Statistically significant for unadjusted data.